Patent ID: 8440837

Claim:
A compound of formula (I): wherein: X is —CONR 3 R 4 , wherein: R 3 is hydrogen or C 1 -C 6 alkyl; R 4 is unsubstituted C 1 -C 6 alkyl, or R 4 may be cycloalkyl, or heterocyclyl, each of which is optionally mono-, di-, or tri-substituted independently with C 1 -C 6 alkyl, halogen, cycloalkyl, and aryl; or R 3 and R 4 taken together with the N to which they are attached to form a 4 to 10 membered heterocyclyl, which optionally contains at least one additional heteroatom and optionally is mono-, di-, or tri-substituted independently with C 1 -C 6 alkyl, hydroxy, C 1 -C 6 alkoxy, C 1 -C 6 alkoxyalkyl, C 1 -C 6 cycloalkyl, CO 2 C 1 -C 6 alkyl, hydroxyalkyl, —CN, —NH 2 , —NH(C 1 -C 3 alkyl), —N(C 1 -C 3 alkyl) 2 , —NHCOC 1 -C 6 alkyl, acyl, aryl, heteroaryl, heterocyclyl, heterocyclyl-C 1 -C 6 alkyl, ═O, and halogen; R 1 is hydrogen, C 1 -C 6 alkyl, C 3 -C 6 cycloalkyl, aryl or heteroaryl, which is optionally mono-, or di-substituted independently with C 1 -C 3 alkyl, C 1 -C 3 alkoxy, hydroxyl, CF 3 , CHF 2 , CN and halogen; R 2 is hydrogen, C 1 -C 3 alkyl, CF 3 , CHF 2 , or halogen; with the proviso that X and R 2 are attached either to the fourth or fifth carbon of the thiazole ring and when X is attached to the fourth carbon, R 2 is attached to the fifth carbon and vice versa; or a pharmaceutically-acceptable salt thereof.